ProductsPricingResearchSupportPartner
​

Login
Open Account
Home > IPO > Entero Healthcare Solutions Ltd IPO

₹ 13838 / 11 shares

IPO Details

RHP/DRHP

Issue Date

09 Feb - 13 Feb'24

Investment/lot

₹ 13838

Price Range

1195 - 1258

Lot Size

11

IPO Size

₹ 1600.84 Cr

IPO Listing Details

Listing On

16 Feb'24

Issue Price

1258

Listed Price

₹ 1245

Retail Gain/Listing Gain

▼-2.33%

Start date

09/02/2024

End date

13/02/2024

Allotment of bids

14/02/2024

Refund Initiation

15/02/2024

Listing on exchange

16/02/2024

IPO Timeline

Entero Healthcare Solutions is amongst the top three healthcare product distributors in India, in terms of revenue, and reported an operating income of Rs. 25,220.65 million in FY22 (Source: CRISIL Report).

The company essentially provides reach and accessibility to pharmacies, hospitals and clinics through its integrated and technology-driven, pan-India distribution platform for healthcare products.

With that, let's take a look at the competitive strengths and risk factors for Entero Healthcare Solutions Limited:

Competitive Strengths

One of India’s largest and fastest-growing healthcare products distribution platforms

Aside from being amongst the top three healthcare product distributors in India, the company also achieved the fastest scale-up of operations among healthcare product distributors in India (between FY19 to FY22) and reached Rs. 25,000 million of operating income within four years of operations (Source: CRISIL Report).

Track record of inorganic expansion and integration to grow geographic reach, revenues and scale

Since the inception of the company in FY18, it has acquired 32 entities in the healthcare products distribution industry. After the completion of an acquisition, the company deploys growth strategies such as product portfolio expansion, increased customer reach, improved service levels and technology-based solutions to increase market share.

The company operates in a large and highly fragmented Indian healthcare product distribution market

According to the CRISIL Report, the target addressable market for pharmaceutical distributors in India is valued at Rs. 2.7 trillion in FY23 and is expected to grow at 10% to 11% CAGR from FY23 to FY28. The company believes that it will be able to benefit from the market consolidation in India and continue expanding the business through future strategic acquisitions of local distributors.
Watch and Learn
All you need to know about Entero healthcare Solutions IPO
Tune in to know more about the company, IPO issue details, future strategies, important financial details, its presence and reach, product/service portfolio, and much more with Kinjal Parekh!
Entero Healthcare Solutions IPO Review | Issue details, future strategies & more

Entero Healthcare Solutions IPO Review | Issue details, future strategies & more

Kotak Securities

•

3m 55s

Risk Factors

  • If the company is unable to identify expansion opportunities, it will experience delays in implementing its inorganic growth strategy.
  • The company may be unable to manage its growth if it is not able to efficiently operate, maintain or expand the supply chain and distribution infrastructure.
  • Risks associated with the company’s information technology systems may adversely affect the business.

Key Strategies

  • Benefit from the market consolidation with strategic acquisitions.
  • Strengthen market position through increases in customer base, wallet share and geographic penetration.
  • Expand product adjacencies, private label and service offerings.

Entero Healthcare Solutions Ltd Key Financials

Here are the key financials for Entero Healthcare Solutions Limited:

Particulars (in Rs. million)

Particulars (in Rs. million)

What are you looking for?
Applying for an IPO for the first time?
Here's a video playlist to help you invest in the upcoming Entero Healthcare Solutions Ltd
How to apply for IPO through ASBA

How to apply for IPO through ASBA

Kotak Securities

•

4m 01s

How to apply for an IPO using UPI

How to apply for an IPO using UPI

Kotak Securities

•

01m 19s

title

How to apply for an IPO using UPI

Kotak Securities • 01m 19s

Opening of account will not guarantee allotment of shares in IPO. Investors are requested to do their own due diligence before investing in any IPO.

Here are the steps to apply for Entero Healthcare Solutions Ltd IPO:

Step 1: Log in to your Kotak Securities Demat account Log in to your Demat account to access IPO investments. Next, select the current IPO section.

Step 2: Specify IPO details Enter the number of lots and the price you wish to apply for.

Step 3: Enter UPI ID After entering your UPI ID, click submit. This will place your bid with the exchange.

Step 4: Mandate Notification Your UPI app will receive a mandate notification to block funds.

Step 5: Approve Request Your funds will be blocked once you approve the mandate request on your UPI.

Entero Healthcare Solutions Ltd IPO FAQs

Entero Healthcare Solutions Ltd IPO will list on 2024-02-16.

1600.84 is the issue size of Entero Healthcare Solutions Ltd IPO.

The minimum lot size is 11 shares and the investment required is ₹13838.

The price band of Entero Healthcare Solutions Ltd IPO is ₹1195 to ₹1258.

You can read more about Entero Healthcare Solutions Ltd and its IPO from the company’s red herring prospectus (RHP) here.

The Entero Healthcare Solutions Limited IPO has an issue size of Rs. 1,000 crores. The IPO opens for subscription on 9th February 2024 and closes on 13th February 2024.

Link Intime India Private Limited is the registrar for this IPO.

You may read more about Entero Healthcare Solutions Limited and its IPO from the company’s draft red herring prospectus (DRHP) here:

Open Demat Account to Invest in any IPO
+91 -

Open Demat Account
personImage
Download App
Open Account
Open Demat Account to Invest in any IPO
+91 -

Open Demat Account
personImage